UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced a financing agreement with Oberland Capital and provided preliminary, estimated revenue for the second quarter ended June 30, 2020. The financing agreement provides up to $75 million in … Continue reading Axogen Announces New Seven-Year Financing Agreement With Oberland Capital